IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients

NCT05641545 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Premature discontinuation due to üoor participant recruitment

Conditions

Advanced Renal Cell Carcinoma

Interventions

BIOLOGICAL: IVAC

Sponsor

SLK Kliniken Heilbronn GmbH